Protein A Resins Market
A Detailed Analysis of Protein A Resins Market by Natural Protein A Resin and Recombinant Protein A Resin
Biologic Therapies Emerging as a Promising Therapy Due to Its Positive Results. FMI Explores Emerging Investment Pockets Across the Globe
Protein A Resins Market Snapshot (2023 to 2033)
The global protein A resins market is slated to reach US$ 677.84 million in 2023. According to Future Market Insights' recent study, the market is projected to attain US$ 1,477.01 million by 2033. From 2023 to 2033, the market is expected to register a CAGR of 8.1%.
In terms of product, the market has been bifurcated between natural protein A resin and recombinant protein A resin. FMI has forecast the demand for natural protein A resin to account for maximum sales in the protein A resin market through the assessment period.
| Data Points | Market Insights |
|---|---|
| Protein A Resins Market Value 2023 | US$ 677.84 million |
| Protein A Resins Market Value 2033 | US$ 1,477.01 million |
| Protein A Resins Market CAGR 2023 to 2033 | 8.1% |
| Key Players |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How are Contract Manufacturing Organizations (CMOs) Contributing Towards Market Growth?
Increasing production of monoclonal antibodies in contract manufacturing organizations is expected to drive revenue growth for the overall protein A resins market over the forecast period. The trend for manufacturing biologics in CMOs started in the 1980s. Over the last few years, the trend in CMOs has changed drastically, shifting from manufacturing blockbuster drugs to specialist care drugs, including monoclonal antibodies.
Very few companies have in-house manufacturing capabilities. The management of the supply chain adds to the complexity of manufacturing processes. The establishment of such high-containment biologic facilities requires higher investment, which can be a great financial risk. Thus, contract manufacturing organizations (CMOs) are outsourced to develop and produce monoclonal antibodies, driven by the increasing need for biotechnology companies that require unique development expertise and facilities.
Contract manufacturing organizations are expected to play an important role in the production of active pharmaceutical ingredients and biologics, including monoclonal antibodies, thereby opening up new revenue pockets in the protein A resins.
What are the Surfacing Opportunities for Market Players?
The increasing prevalence of cancer is expected to increase the production of monoclonal antibodies for use in therapeutic areas. The potential application of monoclonal antibodies in diagnosing and treating various cancer types has been widely accepted. Each cancer type requires a unique treatment. Thus, it is expected to provide opportunities for market players by driving sales of protein A resin over the forecast period.
Increasing the use of monoclonal antibodies in various therapeutic areas owing to their flexibility and specificity and the need for protein A resin is expected to drive the sales of protein A resins over the forecast period.
Many pharmaceutical and biotechnological companies are researching and developing (R&D) on monoclonal antibodies to find new therapeutic areas. Companies are already manufacturing monoclonal antibody products for therapeutic areas such as cardiovascular, immune therapy, microbial infections, inflammatory disorders, Crohn's disease, transplants, and certain types of cancer such as leukemia and breast cancer.
The biologics segment in the life sciences industry has gained acceptance by biotechnology and other research institutes for their areas of research, as it has shown promising results as well as low side effects in the treatment of different diseases, such as cancer, autoimmune diseases, and certain genetic conditions.
Biologic therapies, being more target-mediated than non-biologic treatments, are also used as a first-line treatment in some cancer cases. Biologics is the fastest-growing segment in the healthcare industry, with monoclonal antibodies being the key product.
The growing biologics segment is thus expected to offer lucrative growth opportunities for protein A resin manufacturers in the near future.
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
2018 to 2022 Protein A Resins Demand Outlook Compared to 2023 to 2033 Forecast
According to Future Market Insights (FMI), the sales of protein A resins have grown at a CAGR of nearly 4.8% between 2018 and 2022. Increasing research on monoclonal antibodies (mAbs), CMO's role in mAbs manufacturing, wide therapeutic application of mAbs, production of next-generation protein A resins overcoming ligand leaching issues, and favorable government policies and funding are expected to drive the sales of protein A resins and also provides a positive impetus on the market growth.
Manufacturers are financing research and development activities to come about advanced protein A chromatography resins or their alternatives to address the high cost and operational bottlenecks associated with it. Followed by mergers, acquisitions, collaborations, and product launches through extensive research and development for strengthening product portfolios are the key strategies adopted by manufacturers to increase their revenue. Adopting these strategies helped the companies spread their regional presence and diversify their product offerings.
For instance, in September 2021, Purolite Life Sciences announced the commercialization of two novel next-generation chromatography resins, Praesto Jetted A50 HipH, and Praesto® Jetted (dT)18-DVB, in association with Repligen.
In June 2021, Thermo Fisher Scientific Inc. collaborated with Newomics, a commercial-stage biotechnology company, to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform which can support various LC−MS applications. The agreement is expected to help improve the throughput and robustness of microflow LC-MS in proteomics and biopharmaceutical applications.
Future Market Insights expects the protein A resins market to register a CAGR of 8.1% by the end of 2033. The growth is attributed to the rise in research and development activities for innovative technology development. Leading companies actively participate in approval, partnership, collaboration, merger, and acquisitions to expand their market presence and strengthen product portfolios.
| Historical CAGR (2018 to 2022) | 4.8% |
|---|---|
| Forecast CAGR % (2023 to 2033) | 8.1% |
Comparative View of the Protein A Resins Market
Protein A Resins Market:
| Attributes | Protein A Resins Market |
|---|---|
| CAGR (2023 to 2033) | 8.1% |
| Market Value (2033) | US$ 1,477.01 million |
| Opportunity | The growth of the biologics industry is expected to cultivate growth prospects for active competitors in the market. |
| Key Trends | Shooting up of contract manufacturing organizations is expected to facilitate the smooth growth of businesses providing protein A resins. |
Protein Crystallization and Crystallography Market:
| Attributes | Protein Crystallization and Crystallography Market |
|---|---|
| CAGR (2023 to 2033) | 9.6% |
| Market Value (2033) | US$ 3.53 billion |
| Opportunity | The high expenditure on research and innovation by pharmaceutical firms is expected to create an environment conducive to future growth. |
| Key Trends | Protein crystallization and crystallography are being increasingly opted as a treatment for chronic diseases like cancer, diabetes, etc. |
Protein Degeneration Therapy Market:
| Attributes | Protein Degeneration Therapy Market |
|---|---|
| CAGR (2023 to 2033) | 6.49% |
| Market Value (2033) | 2.72 billion |
| Opportunity | Pharmaceutical firms are partaking in drug development in the therapeutics domain, thus promising significant growth over the forecast period. |
| Key Trends | Dissemination of knowledge promoting the critical benefits of protein degeneration among individuals is the running trend. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Country-wise Insights
Is the United States Expected to Preserve its Leading Position in the Market?
In 2023, the United States is assessed to account for more than 93.5% value share in North America. The demand for protein A resin is increasing in the United States due to the rise in biopharmaceutical companies focusing on developing and commercializing biosimilar drugs in the region. Besides this, improvement in the quality control systems is anticipated to continue augmenting growth in North America.
Why is the United Kingdom Considered a More Lucrative Market within Europe?
The United Kingdom is expected to account for nearly 24.1% of the market in Europe by 2033. The rise in demand for protein A resins in the United Kingdom is primarily due to the increasing requirement for protein therapeutics for the treatment of chronic diseases, the presence of well-established biotechnology and pharmaceutical companies, and rising government funding. Furthermore, a favorable regulatory scenario is likely to offer up new opportunities for the protein A resins market in the United Kingdom.
What are the Factors Supporting Protein A Resins Sales in China?
| Country | China |
|---|---|
| Market CAGR % (2023 to 2033) | 9.8% |
The China market is expected to register a 9.8% CAGR in the East Asia market through the forecast period. The increasing use of biomaterials in drug research, adoption of advanced technologies to leverage healthcare research, expansion of the pharmaceutical industry, and the rising need for vaccines and other therapeutics are the key factors driving the growth in China.
Favorable government policies and growing funding for the expansion of healthcare infrastructure are expected to create a conducive environment for growth in China.
Category-wise Insights
Why is the demand for Natural Protein A Resins Rising?
| Segment | Natural Protein A Resins |
|---|---|
| Market Share % (2023) | 62.8% |
In terms of products, natural protein A resins are expected to capture a maximum market share of 62.8% in 2023. Natural protein A is extracted from a staphylococcus aureus species’ bacterial cell. It is primarily utilized in the cleansing of monoclonal antibodies. It helps in minimizing ligand leaching and stability issues of traditional protein A resins.
What is Driving Sales in the Agarose-based Matrix Segment?
| Segment | Agarose-based Matrix |
|---|---|
| Market Share % (2023) | 85.8% |
In terms of a matrix, the agarose-based matrix of protein A resins is expected to enjoy a market share of 85.8% in 2023, indicating a significant demand in the market. Agarose-based matrix offers high binding specificity when compared with other matrices and are, therefore, extensively used to attach ligands that stick proteins. The running trend is expected to continue, yielding growth in the segment through the forecast period.
Which is the Chief Application of Protein A Resins?
| Segment | Antibody Purification |
|---|---|
| Market Share % (2023) | 74.8% |
By application, the antibody purification of protein A resins segments is expected to account for 74.8% of the market share in 2023. Sales in the segment are primarily steered by demand from large-scale industries like biopharmaceuticals to isolate monoclonal antibodies.
Who is the Leading End User?
| Segment | Biopharmaceutical Manufacturers |
|---|---|
| Market Share % (2023) | 79.2% |
The biopharmaceutical manufacturers are expected to record 79.2% of the market share in 2023. The rising demand for protein engineering with various advancements and harnessing new scientific advances is likely to fuel demand in the segment.
New Initiatives to Increase the Trading of Protein A Resins are Bankrolled by Leading Players
Companies operating in the protein A resins market are taking proactive measures to invigorate their position via approval, collaborations, merger & acquisition partnerships, and agreements with established as well as emerging market players. The product launch and acquisition accelerate the manufacturer’s plan to capitalize on the market share and seize a significant share of the market. Some recent instances include:
- In June 2021, Bio-Rad Laboratories, Inc. joined forces with Seegene, Inc., a leading innovator in multiplex molecular diagnostics. With this partnership, commercialization and clinical development of infectious disease molecular diagnostic products are expected to come to fruition.
- Thermo Fisher Scientific Inc. publicized the founding of a new manufacturing plant in Nashville in September 2021. The manufacturing facility is going to produce single-use technology products, which are expected to enable a reliable supply of critical materials used in the production of new biologics and vaccines.
- In June 2020, Kaneka Corporation and the National Institute of Infectious Diseases collaborated on a combined project on the growth of virus-neutralizing antibodies for the therapy of novel coronavirus infection. The collaboration was made to accelerate the development of therapeutic drugs for treating COVID-19. The Japan Agency for Medical Research and Development (AMED) provided financial support for the same COVID-19 therapeutic drug development program.
- In March 2020, Danaher acquired Cytiva, a life sciences division with the biopharma business of General Electric Company (GE), for a cash purchase price of around US$ 20.7 billion.
- In February 2021, Purolite Life Sciences commercially released NGL COVID-19 Spike Protein Affinity Resin, a novel affinity resin used to purify coronavirus vaccines.
- The greater the demand for active products, the stronger the pipeline, which is expected to lead to increased demand for the industry. Key industry players are concentrating their endeavors on the development and introduction of technologically advanced protein A resins. There are huge opportunities for the market players to invest in protein A resins.
Key Players in the Market are
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
Scope of the Protein A Resins Market Report
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million/ billion for Value |
| Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product, Matrix, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Protein A Resins Market by Category
Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
Matrix:
- Agarose-based Matrix
- Glass or Silica-based Matrix
- Organic Polymer-based Matrix
Application:
- Immunoprecipitation
- Antibody Purification
End User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Frequently Asked Questions
How Big is the Protein A Resins Market?
As of 2023, the global market size could stand at US$ 677.84 million.
What is the Protein A Resins Market Growth?
The global demand for Protein A Resins could witness 8.1% CAGR through 2033.
What is the Share of Natural Protein A Resins Market Segment?
The overall segment is expected to account for 62.8% of the global market in 2023.
What will be the Total Share of United States Protein A Resins Market in 2023?
The regional market is forecasted to account for 93.5% of North America Market.
How will China Protein A Resins Market Perform during the Forecast Years?
China market is poised to follow an impressive 9.8% CAGR up to 2033.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Natural Protein A Resin 5.3.2. Recombinant Protein A Resin 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Matrix 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Matrix, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Matrix, 2023 to 2033 6.3.1. Agarose Based Matrix 6.3.2. Glass or Silica Based Matrix 6.3.3. Organic Polymer Based Matrix 6.4. Y-o-Y Growth Trend Analysis By Matrix, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Matrix, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033 7.3.1. Immunoprecipitation 7.3.2. Antibody Purification 7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Biopharmaceutical Manufacturers 8.3.2. Clinical Research Laboratories 8.3.3. Academic Institutes 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA. 10.2.1.2. Canada 10.2.2. By Product 10.2.3. By Matrix 10.2.4. By Application 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Matrix 10.3.4. By Application 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product 11.2.3. By Matrix 11.2.4. By Application 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Matrix 11.3.4. By Application 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Product 12.2.3. By Matrix 12.2.4. By Application 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Matrix 12.3.4. By Application 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Product 13.2.3. By Matrix 13.2.4. By Application 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Matrix 13.3.4. By Application 13.3.5. By End User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Product 14.2.3. By Matrix 14.2.4. By Application 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Matrix 14.3.4. By Application 14.3.5. By End User 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Product 15.2.3. By Matrix 15.2.4. By Application 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Matrix 15.3.4. By Application 15.3.5. By End User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product 16.2.3. By Matrix 16.2.4. By Application 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product 16.3.3. By Matrix 16.3.4. By Application 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA. 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Product 17.1.2.2. By Matrix 17.1.2.3. By Application 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Product 17.2.2.2. By Matrix 17.2.2.3. By Application 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Product 17.3.2.2. By Matrix 17.3.2.3. By Application 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Product 17.4.2.2. By Matrix 17.4.2.3. By Application 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Product 17.5.2.2. By Matrix 17.5.2.3. By Application 17.5.2.4. By End User 17.6. United Kingdom. 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Product 17.6.2.2. By Matrix 17.6.2.3. By Application 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Product 17.7.2.2. By Matrix 17.7.2.3. By Application 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Product 17.8.2.2. By Matrix 17.8.2.3. By Application 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Product 17.9.2.2. By Matrix 17.9.2.3. By Application 17.9.2.4. By End User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Product 17.10.2.2. By Matrix 17.10.2.3. By Application 17.10.2.4. By End User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Product 17.11.2.2. By Matrix 17.11.2.3. By Application 17.11.2.4. By End User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Product 17.12.2.2. By Matrix 17.12.2.3. By Application 17.12.2.4. By End User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Product 17.13.2.2. By Matrix 17.13.2.3. By Application 17.13.2.4. By End User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Product 17.14.2.2. By Matrix 17.14.2.3. By Application 17.14.2.4. By End User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Product 17.15.2.2. By Matrix 17.15.2.3. By Application 17.15.2.4. By End User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Product 17.16.2.2. By Matrix 17.16.2.3. By Application 17.16.2.4. By End User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Product 17.17.2.2. By Matrix 17.17.2.3. By Application 17.17.2.4. By End User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Product 17.18.2.2. By Matrix 17.18.2.3. By Application 17.18.2.4. By End User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Product 17.19.2.2. By Matrix 17.19.2.3. By Application 17.19.2.4. By End User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Product 17.20.2.2. By Matrix 17.20.2.3. By Application 17.20.2.4. By End User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Product 17.21.2.2. By Matrix 17.21.2.3. By Application 17.21.2.4. By End User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Product 17.22.2.2. By Matrix 17.22.2.3. By Application 17.22.2.4. By End User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Product 17.23.2.2. By Matrix 17.23.2.3. By Application 17.23.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product 18.3.3. By Matrix 18.3.4. By Application 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. GE Healthcare 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Thermo Fisher Scientific 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Kaneka Corporation, 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. JNC Corporation 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Purolite Life Sciences 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Bio-Rad Laboratories, Inc. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. JSR Corporation (JSR Life Sciences LLC) 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Repligen 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Tosoh Bioscience, Merck Group (Merck Millipore) 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Novasep Holdings SAS, Agilent Technologies, Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.11. GenScript, Abcam PLC (Expedeon Ltd.) 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.12. Avantor Inc. 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.13. Takara Bio, PerkinElmer, Inc. 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 19.1.14. Suzhou Nanomicro Technology Co., Ltd 19.1.14.1. Overview 19.1.14.2. Product Portfolio 19.1.14.3. Profitability by Market Segments 19.1.14.4. Sales Footprint 19.1.14.5. Strategy Overview 19.1.14.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: Western Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 18: Western Europe Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 19: Western Europe Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 20: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 21: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: Eastern Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 23: Eastern Europe Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 24: Eastern Europe Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 25: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 26: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 27: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 28: South Asia and Pacific Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 29: South Asia and Pacific Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 30: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 31: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 33: East Asia Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 34: East Asia Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 35: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 36: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 38: Middle East and Africa Market Value (US$ Million) Forecast by Matrix, 2018 to 2033 Table 39: Middle East and Africa Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 40: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Application , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 12: Global Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 15: Global Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 18: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 21: Global Market Attractiveness by Product, 2023 to 2033 Figure 22: Global Market Attractiveness by Matrix, 2023 to 2033 Figure 23: Global Market Attractiveness by Application , 2023 to 2033 Figure 24: Global Market Attractiveness by End User, 2023 to 2033 Figure 25: Global Market Attractiveness by Region, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Product, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Application , 2023 to 2033 Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 46: North America Market Attractiveness by Product, 2023 to 2033 Figure 47: North America Market Attractiveness by Matrix, 2023 to 2033 Figure 48: North America Market Attractiveness by Application , 2023 to 2033 Figure 49: North America Market Attractiveness by End User, 2023 to 2033 Figure 50: North America Market Attractiveness by Country, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by Product, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) by Application , 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 59: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 62: Latin America Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 71: Latin America Market Attractiveness by Product, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Matrix, 2023 to 2033 Figure 73: Latin America Market Attractiveness by Application , 2023 to 2033 Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 76: Western Europe Market Value (US$ Million) by Product, 2023 to 2033 Figure 77: Western Europe Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 78: Western Europe Market Value (US$ Million) by Application , 2023 to 2033 Figure 79: Western Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 80: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 81: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 84: Western Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 87: Western Europe Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 90: Western Europe Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 93: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 94: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 96: Western Europe Market Attractiveness by Product, 2023 to 2033 Figure 97: Western Europe Market Attractiveness by Matrix, 2023 to 2033 Figure 98: Western Europe Market Attractiveness by Application , 2023 to 2033 Figure 99: Western Europe Market Attractiveness by End User, 2023 to 2033 Figure 100: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: Eastern Europe Market Value (US$ Million) by Product, 2023 to 2033 Figure 102: Eastern Europe Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 103: Eastern Europe Market Value (US$ Million) by Application , 2023 to 2033 Figure 104: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 105: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 106: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 112: Eastern Europe Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 115: Eastern Europe Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 118: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 121: Eastern Europe Market Attractiveness by Product, 2023 to 2033 Figure 122: Eastern Europe Market Attractiveness by Matrix, 2023 to 2033 Figure 123: Eastern Europe Market Attractiveness by Application , 2023 to 2033 Figure 124: Eastern Europe Market Attractiveness by End User, 2023 to 2033 Figure 125: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 126: South Asia and Pacific Market Value (US$ Million) by Product, 2023 to 2033 Figure 127: South Asia and Pacific Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 128: South Asia and Pacific Market Value (US$ Million) by Application , 2023 to 2033 Figure 129: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 130: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 131: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 132: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 133: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 134: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 138: South Asia and Pacific Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 139: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 140: South Asia and Pacific Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 141: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 142: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 143: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 144: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 145: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 146: South Asia and Pacific Market Attractiveness by Product, 2023 to 2033 Figure 147: South Asia and Pacific Market Attractiveness by Matrix, 2023 to 2033 Figure 148: South Asia and Pacific Market Attractiveness by Application , 2023 to 2033 Figure 149: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033 Figure 150: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 151: East Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 152: East Asia Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 153: East Asia Market Value (US$ Million) by Application , 2023 to 2033 Figure 154: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 155: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 156: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 158: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 159: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 160: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 161: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 162: East Asia Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 163: East Asia Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 165: East Asia Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 166: East Asia Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 167: East Asia Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 168: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 169: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 170: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 171: East Asia Market Attractiveness by Product, 2023 to 2033 Figure 172: East Asia Market Attractiveness by Matrix, 2023 to 2033 Figure 173: East Asia Market Attractiveness by Application , 2023 to 2033 Figure 174: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 175: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 176: Middle East and Africa Market Value (US$ Million) by Product, 2023 to 2033 Figure 177: Middle East and Africa Market Value (US$ Million) by Matrix, 2023 to 2033 Figure 178: Middle East and Africa Market Value (US$ Million) by Application , 2023 to 2033 Figure 179: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033 Figure 180: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 182: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 183: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 184: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 185: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 186: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 187: Middle East and Africa Market Value (US$ Million) Analysis by Matrix, 2018 to 2033 Figure 188: Middle East and Africa Market Value Share (%) and BPS Analysis by Matrix, 2023 to 2033 Figure 189: Middle East and Africa Market Y-o-Y Growth (%) Projections by Matrix, 2023 to 2033 Figure 190: Middle East and Africa Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 191: Middle East and Africa Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 192: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 193: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 194: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 195: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 196: Middle East and Africa Market Attractiveness by Product, 2023 to 2033 Figure 197: Middle East and Africa Market Attractiveness by Matrix, 2023 to 2033 Figure 198: Middle East and Africa Market Attractiveness by Application , 2023 to 2033 Figure 199: Middle East and Africa Market Attractiveness by End User, 2023 to 2033 Figure 200: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
